Saturday, 24 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Drug
Eli Lilly to Invest $1B in India, Launch New Hyderabad Manufacturing Hub
October 9, 2025
Company
Drug
Walvax Biotech Wins Jordan FDA Approval for 13‑Valent Pneumococcal Vaccine
October 9, 2025
Company
Drug
Northeast Pharma Secures NMPA Approval for DCTY0801 Injection Targeting EGFRvIII‑Positive Brain Gliomas
October 9, 2025
Company
Deals
InnoCare, Zenas, Orelabrutinib: $2 B Licensing Deal Fuels MS Therapeutic Pipeline
October 9, 2025
Company
Drug
Hengrui, SHR‑4298, RAS: China Approves Two Novel Anti‑Tumor Drugs for Clinical Trials
October 9, 2025
Company
Drug
Shanghai Fosun Secures NMPA Approval for HLX43 + HLX07 Combination in Advanced Solid Tumors
October 9, 2025
1
2
…
17
18
19
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?